Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ES014 in Adult Subjects With Desmoid Tumors
NCT07541430Phase 2Recruiting
- Sponsor
- Elpiscience
- Start
- Apr 2026
- Primary completion
- Jan 2028
- Modality
- Bispecific Antibodies, Fc Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of ES014 in desmoid tumor, sponsored by Elpiscience. Started Apr 2026; status: recruiting.
02
Drugs
ES014
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT07541430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07541430.